Biomarker Industry 2026

North American Biomarker Industry 2026‑2030

North America biomarker market forecast at $63B by 2030, 12.7% CAGR. Assesses Thermo Fisher, Abbott, Roche and Quest Diagnostics positioning. Covers income data, infrastructure and full forecasts 2026-2030.

US Biomarker Industry 2026‑2030

US biomarker market valued at $32.5B in 2025, on track for $58B by 2030. Market share analysis of Thermo Fisher, Roche, Abbott and Bio-Rad. Covers client wins, segment forecasts and growth trends through 2030.

Global Biomarker Industry 2026‑2030

Global biomarker market valued at $86B in 2025, projected $152B by 2030. Covers Thermo Fisher, Roche, Abbott, QIAGEN and Bio-Rad worldwide. Includes market trends, sales data and segment forecasts 2026-2030.

European Biomarker Industry 2026‑2030

Europe biomarker market estimated at $22.4B in 2025, reaching $37B by 2030. Tracks Roche, QIAGEN, bioMerieux, DiaSorin and Siemens Healthineers. Includes product launches, infrastructure and forecasts to 2030.

North European Biomarker Industry 2026‑2030

• 50+ reports

• Merger and Acquisition, Product Launch, Income Data…

Asian Biomarker Industry 2026‑2030

Asia biomarker market projected to grow from $18.6B to $34.2B by 2030. Tracks M&A activity among Thermo Fisher, Sysmex, BGI and regional players. Includes market size, infrastructure outlook and segment forecasts 2026-2030.

UK Biomarker Industry 2026‑2030

UK biomarker market valued at $3.7B in 2025, projected $6.2B by 2030. Market share analysis of Abcam, Oxford Nanopore, Roche UK and Abbott. Covers production data, economic analysis and forecasts to 2030.

Oceanian Biomarker Industry 2026‑2030

• 30+ reports

• Market Share, Income Data…